Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With High-Risk Hematologic Diseases
Conditions
- Acute Leukemia of Ambiguous Lineage
- Acute Lymphoblastic Leukemia
- Acute Myeloid Leukemia
- Blastic Plasmacytoid Dendritic Cell Neoplasm
- Hematopoietic and Lymphatic System Neoplasm
- Mixed Phenotype Acute Leukemia
- Myelodysplastic Syndrome
- Myeloproliferative Neoplasm
- Non-Hodgkin Lymphoma
- Chronic Myeloid Leukemia, BCR-ABL1 Positive
Interventions
- PROCEDURE: Biospecimen Collection
- PROCEDURE: Bone Marrow Aspirate
- DRUG: Cyclophosphamide
- DRUG: Cyclosporine
- PROCEDURE: Diagnostic Imaging
- PROCEDURE: Echocardiography
- DRUG: Fludarabine Phosphate
- PROCEDURE: Multigated Acquisition Scan
- DRUG: Mycophenolate Mofetil
- OTHER: Survey Administration
- DRUG: Thiotepa
- RADIATION: Total-Body Irradiation
- PROCEDURE: Umbilical Cord Blood Transplantation
Sponsor
Fred Hutchinson Cancer Center
Collaborators